The STEP 1 trial for semaglutide 2.4mg demonstrated a mean body weight reduction of approximately 14.9% over 68 weeks in adults with obesity. The SURMOUNT-1 trial for tirzepatide showed reductions of up to 22.5% at the highest dose. These are outcomes that approach the efficacy of bariatric surgery in some patient cohorts
They're biologically inert
Real-World Applications for Athletes Some of the most common conditions we support using peptides for muscle recovery include: Hamstring or calf strains Rotator cuff recovery Quadriceps or biceps overuse Tendonitis (Achilles, patellar, elbow) Post-competition inflammation and fatigue We emphasize that BPC-157 and TB-500 are adjunct therapiesnot standalone cures
These protocols account for timing, dosing, and synergistic effects to optimize your results while minimizing complexity
Using them together can be more effective for treating hyperpigmentation than using either one alone
Serious but less common risks may include: hypersensitivity reactions, hypokalemia (rare, with B12 correction of severe deficiency), and exacerbation of polycythemia